Japanese Medtech Startup, CoreTissue BioEngineering, Initiates Randomized Controlled Cohort in the Clinical Trial for Anterior Cruciate Ligament (ACL) Reconstruction Treatment

CoreTissue BioEngineering Inc. ("CTBE"), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture, CEO: Yoji Jokura, Ph.D.) announces that the safety evaluation in the safety cohort ...

Australia has the world's highest rate of ACL reconstruction surgery—rehab may be just as good

If you've ever watched a game of Australian rules football, rugby league or basketball, you've probably seen it happen: a ...